Related Experiment Video
Updated: Jan 24, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Sinerga may prevent recurrent respiratory infections in allergic children
1Otorhinolaryngology Unit, Villa Montallegro, Genoa, Italy.
Insights
This study shows that Sinerga, a dietary supplement, significantly reduced recurrent respiratory infections (RRI) in allergic children. Supplementation also decreased turbinate size, suggesting a role in managing allergic inflammation.
Area of Science:
- Immunology
- Otolaryngology
- Pediatrics
Background:
- Recurrent respiratory infections (RRI) pose a significant clinical challenge, particularly in allergic children.
- Modulating the immune system is a potential strategy for preventing RRI.
Discussion:
- Sinerga, a supplement containing palmitoylethanolamide (PEA), Kluyveromyces marxianus B0399, bovine colostrum, and phenylalanine, was investigated.
- The study compared Sinerga plus standard therapy (antihistamine and intranasal corticosteroid) against standard therapy alone in allergic children with RRI.
Key Insights:
- Sinerga supplementation significantly reduced the incidence of respiratory infections in allergic children.
- A notable reduction in the size of inferior and middle turbinates was observed in the Sinerga group.
- These findings align with the proposed immune-modulating mechanisms of Sinerga's components.
Outlook:
- Sinerga demonstrates potential as an adjunct therapy for preventing RRI in allergic pediatric populations.
- Further research could explore the specific contributions of each Sinerga component to immune modulation and symptom reduction.
Abstract:
Recurrent respiratory infections (RRI) are an intriguing challenge for both otolaryngologists and paediatricians. Therefore, to prevent RRI is an ambitious target in clinical practice. In this regard, modulation of the immune system may have a critical role. Sinerga, a dietary supplement (containing: palmitoylethanolamide (PEA), Kluyveromyces marxianus B0399, bovine colostrum, and phenylalanine), was supplemented in 20 allergic children with RRI (20/30 days per 3 months) and treated with standard therapy (antihistamine plus intranasal corticosteroid). Other 20 allergic children with RRI were treated only with standard therapy. Sinerga significantly reduced the number of RI and the size of both inferior and middle turbinate consistently with the postulated mechanisms of action. In conclusion, the current study demonstrated that Sinerga supplementation in allergic children with RRI may significantly prevent RI and reduce events depending on allergic inflammation.
More Related Videos
08:53Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Related Concept Videos
Allergic Reactions
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Allergic Drug Reactions
Cancer Prevention
Some...
Anatomy of Respiratory System II: Lower Respiratory Tract
The Larynx
It is located between the pharynx and the trachea, acts as a passageway for air, and hosts several critical structures, such as the epiglottis, vocal cords, and glottis. The epiglottis acts as a gateway, guiding food to the...
The Respiratory System